Class | CCY | SZE(M) | WAL | MO | SP | FI | DR | KR | C/E | LTV | TYPE | BNCH | GDNC | SPRD | CPN | YLD | PRICE |
---|
A | OZJ | 53.000 | - | - | RR | - | - | - | 92.00% | - | Vwhwbvfx | SGNC | 180-185 | 180 | CLQZ+180 | - | - |
C | RNA | 82.000 | - | - | Q | - | - | - | 26.00% | - | - | - | - | - | - | - | Retained |
Yer | VSI | 84.400 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | Retained |
S | HUY | 298.000 | - | - | III | - | - | - | 58.00% | - | Udexumef | YBHA | 150-153 | 155 | KSTD+155 | - | - |
Tranche Comments
S: Redemption: 2027-03-20; Registration: 144G/Jah W;
A: Redemption: 2027-03-20; Registration: 144T/Fih A;
C: Redemption: 2027-03-20; Registration: 144A/Ihl G;
Yer: Redemption: 2027-03-20; Registration: 144T/Bsc M;
Reinvestment Period (YRS)
4
Reinvestment Period End Date
Jul 7, 2008